We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

71 hedge funds and large institutions have $331M invested in Syneron Medical Ltd in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

18% more capital invested

Capital invested by funds: $280M → $331M (+$51.3M)

6% more funds holding

Funds holding: 6771 (+4)

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

Holders
71
Holders Change
+4
Holders Change %
+5.97%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
12
Increased
22
Reduced
21
Closed
8
Calls
$26K
Puts
Net Calls
+$26K
Net Calls Change
+$31K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.26M +$579K +48,864 +94%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.23M +$172K +14,490 +17%
TA
28
Teton Advisors
New York
$1.18M
PIM
29
Platinum Investment Management
Australia
$1.17M
DCM
30
DAFNA Capital Management
California
$1.13M
SCA
31
SAC Capital Advisors
Connecticut
$1.06M +$1.01M +85,000 New
TC
32
TFS Capital
Pennsylvania
$937K -$149K -12,545 -14%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$850K +$367K +30,961 +83%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$795K +$386K +32,600 +104%
BIM
35
Bogle Investment Management
Massachusetts
$748K -$146K -12,363 -17%
DC
36
Davenport & Co
Virginia
$744K +$309K +26,075 +77%
Citadel Advisors
37
Citadel Advisors
Florida
$696K +$497K +41,932 +300%
PCM
38
Penn Capital Management
Pennsylvania
$682K -$1.66M -139,804 -72%
RFC
39
Russell Frank Company
Washington
$682K +$71.8K +6,065 +12%
MC
40
Moors & Cabot
Massachusetts
$567K +$540K +45,551 New
Nomura Holdings
41
Nomura Holdings
Japan
$482K +$466K +39,308 New
DM
42
Deerfield Management
New York
$430K +$409K +34,518 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$395K
IAM
44
Iridian Asset Management
Connecticut
$363K -$164K -13,870 -32%
GI
45
GAMCO Investors
Connecticut
$299K
WA
46
Whitebox Advisors
Minnesota
$295K -$59.2K -5,000 -17%
EGA
47
Eagle Global Advisors
Texas
$249K +$35.5K +3,000 +18%
Morgan Stanley
48
Morgan Stanley
New York
$202K +$43K +3,630 +29%
State Street
49
State Street
Massachusetts
$201K +$190K +16,070 New
PP
50
PDT Partners
New York
$195K +$185K +15,654 New

ELOS Hedge Fund Activity: Q1 2014 in Review

71 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2014, worth a combined $331M — up 18% from $280M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ELOS positions and 8 closed out — a net gain of 4 holders — while 22 added to existing stakes and 21 trimmed.

The largest buyer was Senvest Management, opening a new position worth an estimated $43M. The largest seller was Brandes Investment Partners, cutting an estimated $6.98M.

  • 71 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2014, up from 67 in Q4 2013.
  • Funds reported $331M of Syneron Medical Ltd stock for Q1 2014, up 18% quarter-over-quarter.
  • 12 funds opened new Syneron Medical Ltd positions in Q1 2014 and 8 closed out, a net change of +4 holders.
  • The largest Syneron Medical Ltd buyer in Q1 2014 was Senvest Management, an estimated $43M added.
  • The largest Syneron Medical Ltd seller in Q1 2014 was Brandes Investment Partners, an estimated $6.98M sold.

Based on aggregated 13F filings for Q1 2014.